In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Therakos Inc.

Division of Mallinckrodt PLC
www.therakos.com

Latest From Therakos Inc.

Mega Medtech M&A Momentum In 2015

Medtech M&A activity has been on the rise for several years along with a surge in the number of higher-valued mega-deals, those worth at least $1 billion. Yet a survey of all deals with known values indicates that median deal value has actually declined.

Medical Device Deals

Biopharma Quarterly Dealmaking Statistics, Q3 2015

Biopharma financing totaled $9.7 billion, almost half from follow-on public offerings; there was big consolidation in the generics and health services industries. AstraZeneca signed a dozen partnerships, many of which focused on oncology.

BioPharmaceutical Deals

Deals In Depth: August 2015

Following their asset swap last year, GSK handed over to Novartis complete ownership of the CD20 antagonist ofatumumab; Greatbatch acquired privately held Lake Region Medical Holdings for $1.74 billion in cash and stock. Biopharma financing decreased while device fundraising jumped.

Medical Device BioPharmaceutical

Deals Shaping The Medical Industry, September 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Mallinckrodt PLC
  • Senior Management
  • Michael Rechtiene, CEO
    Jamie Oliver, CFO
    Sandra Thompson, Pres. & COO
    Christian Peters, MD, PhD, CMO
  • Contact Info
  • Therakos Inc.
    Phone: (855) 422-9115
    10 N. High St.
    West Chester, PA 19380
    USA
UsernamePublicRestriction

Register